patent
Gastro-intestinal biomarkers for diagnosis and therapies of proteinopathies
2016
Pharmaceutical composition for the treatment of proteinopathies comprising products which are able to stimulate growth or inhibition of at least one of Odoribacter, Oscillospira, Dehalobacterium, Alistipes, Parabacteroides, Lactobacillus and Sutterella, Firmicutes, Bacteroidetes, Allobaculum and Akkermansia bacteria population in the gut of individuals.
Type
patent
EPO Family ID
55361909
Author(s)
Note
Alternative title(s) : (de) Gastrointestinale biomarker zur diagnose und für therapie von proteinopathien (fr) Biomarqueurs gastrointestinaux pour diagnostic et thérapies de protéinopathies
TTO classification
TTO:6.1465
| DOI | Country code | Kind code | Date issued |
US2017360853 | US | A1 | 2017-12-21 |
EP3242673 | EP | A1 | 2017-11-15 |
WO2016110768 | WO | A1 | 2016-07-14 |
Available on Infoscience
May 11, 2017
Use this identifier to reference this record